The Impact of Covid-19 Pandemic on Genitourinary Cancers Stage and Grade

Taheri, Diana; Jahanshahi, Fatemeh; Khajavi, Alireza; Kafi, Fatemeh; Pouramini, Alireza; Farsani, Reza Mohammadi; Alizadeh, Yasamin; Akbarzadeh, Maryam; Reis, Leonardo Oliveira; Khatami, Fatemeh; Aghamir, Seyed Mohammad Kazem

doi:10.1016/j.clgc.2022.11.016

Cited by 6 publications

(14 citation statements)

References 35 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Meanwhile, the proportion of patients in late‐stages was between 25% and 50% in January‐June 2020, which was between 16% and 29% in the same period in 2019. This increase in the proportion of late‐stage patients was similarly observed in breast cancer reported by Kapp 27 and urological cancers reported by Taheri 28 . A possible reason for this is the reduction in screening combined with the lack of obvious symptoms in patients with early‐stage cervical cancer, resulting in untimely attendance 29 .…”

Section: Discussionsupporting

confidence: 57%

“…This increase in the proportion of late-stage patients was similarly observed in breast cancer reported by Kapp 27 and urological cancers reported by Taheri. 28 A possible reason for this is the reduction in screening combined with the lack of obvious symptoms in patients with early-stage cervical cancer, resulting in untimely attendance. 29 Thus, the impact of the COVID-19 pandemic, especially in the initial phase, was more pronounced in the early-stage patients.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Impact of the COVID‐19 pandemic on the hospital attendance of patients with primary cervical cancer in Heilongjiang, China

Qı

Wang

Jia

et al. 2023

Intl Journal of Cancer

View full text Add to dashboard Cite

Information regarding the impact of the coronavirus disease 2019 (COVID‐19) pandemic on cervical cancer in mainland China is lacking. We explored its impact on the hospital attendance of patients with primary cervical cancer. We included 1918 patients with primary cervical cancer who initially attended Harbin Medical University Cancer Hospital between January 23, 2019, and January 23, 2021. Attendance decreased by 31%, from 1135 in 2019 to 783 in 2020, mainly from January to June (𝜒2 = 73.362, P < .001). The percentage of patients detected by screening decreased from 12.1% in January‐June 2019 to 5.8% in January‐June 2020 (𝜒2 = 7.187, P = .007). Patients with stage I accounted for 28.4% in 2020 significantly lower than 36.6% in 2019 (𝜒2 = 14.085, P < .001), and patients with stage III accounted for 27.1% in 2020 significantly higher than 20.5% in 2019 (𝜒2 = 11.145, P < .001). Waiting time for treatment was extended from 8 days (median) in January‐June and July‐December 2019 to 16 days in January‐June (𝜒2 = 74.674, P < .001) and 12 days in July‐December 2020 (𝜒2 = 37.916, P < .001). Of the 179 patients who delayed treatment, 164 (91.6%) were for the reasons of the healthcare providers. Compared to 2019, the number of patients in Harbin or non‐Harbin in Heilongjiang Province and outside the province decreased, and cross‐regional medical treatment has been hindered. The COVID‐19 pandemic has negatively impacted cervical cancer patient attendance at the initial phase. These results are solid evidence that a strategy and mechanism for the effective attendance of cervical cancer patients in response to public health emergencies is urgently needed.

show abstract

Section: Discussionsupporting

confidence: 57%

Section: Discussionmentioning

confidence: 99%

Impact of the COVID‐19 pandemic on the hospital attendance of patients with primary cervical cancer in Heilongjiang, China

Qı

Wang

Jia

et al. 2023

Intl Journal of Cancer

View full text Add to dashboard Cite

show abstract

“…Therefore, being exposed to the COVID‐19 virus during the use of diagnosis modalities, limited capacities for elective surgeries, and patients' reluctance to follow up on their treatment after a definite diagnosis might lead to a delay in either diagnosis or treatment of important cancers. 2 , 3 , 4 , 5 …”

Section: Introductionmentioning

confidence: 99%

“…Moreover, the involvement of most systems in the diagnosis and treatment of a large number of patients with COVID‐19 resulted in less attention to patients with cancer. Therefore, being exposed to the COVID‐19 virus during the use of diagnosis modalities, limited capacities for elective surgeries, and patients' reluctance to follow up on their treatment after a definite diagnosis might lead to a delay in either diagnosis or treatment of important cancers 2–5 …”

Section: Introductionmentioning

confidence: 99%

“…Therefore, being exposed to the COVID-19 virus during the use of diagnosis modalities, limited capacities for elective surgeries, and patients' reluctance to follow up on their treatment after a definite diagnosis might lead to a delay in either diagnosis or treatment of important cancers. [2][3][4][5] Different countries implemented various approaches to resolve this issue. One of these approaches is telemedical services to recognize probable cancer red flags rather than postponing the investigation of unlikely symptoms.…”

mentioning

confidence: 99%

See 1 more Smart Citation

The stage of head and neck diagnosed malignancies in COVID‐19 outbreak versus before outbreak: A retrospective study

2023

Self Cite

View full text Add to dashboard Cite

Background Global COVID‐19 pandemic has affected cancer care systems. Recent studies show that the number of cases diagnosed with cancer has drastically decreased compared to the same period before the pandemic. Therefore, we are confronted with delayed diagnosis of critical cancers. Aim The aim of this study is to investigate whether the stage of known cancers has been affected by delayed diagnosis and to compare the stages of head and neck cancers diagnosed during and before the pandemic. Methods The present study was conducted on 132 patients with malignant head and neck tumors referred to the otolaryngology, head and neck cancer department of Taleghani Hospital from 2019 to 2021. The stage of cancers was compared between two groups of patients with head and neck malignancy referred to the Otolaryngology, Head and Neck Department of the Taleghani Hospital before and during the COVID‐19 outbreak. Results The results from tumor (T), nodes (N), and metastases (M) (TNM) staging ( p ‐value = .015) and T score (value = 0.045) showed that the stage of tumor diagnosed in patients during the COVID‐19 pandemic significantly increased compared to patients diagnosed with a tumor before pandemic. Conclusion In the present study, it was observed that the early symptoms of malignant head and neck tumors have been neglected by patients during COVID‐19 pandemic and resulted in delayed diagnosis. This result may be explained by the fear of COVID‐19 infection in patients, which discouraged them from visiting a doctor at healthcare centers.

show abstract

Radiological Findings as Predictors of COVID-19 Lung Sequelae: A Systematic Review and Meta-analysis

et al. 2023

Self Cite

View full text Add to dashboard Cite

The Impact of Covid-19 Pandemic on Genitourinary Cancers Stage and Grade

Cited by 6 publications

References 35 publications

Impact of the COVID‐19 pandemic on the hospital attendance of patients with primary cervical cancer in Heilongjiang, China

Impact of the COVID‐19 pandemic on the hospital attendance of patients with primary cervical cancer in Heilongjiang, China

The stage of head and neck diagnosed malignancies in COVID‐19 outbreak versus before outbreak: A retrospective study

Radiological Findings as Predictors of COVID-19 Lung Sequelae: A Systematic Review and Meta-analysis

Contact Info

Product

Resources

About